PHOENIX BIOTECH ACQUISITION CEROW
*W EXP 09/01/202 · Equity WRT · CUSIP 71902K113
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersSouth San Francisco, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.01. Options: 1 managers hold calls ($903 notional), 0 hold puts (—).
Trends to Q4 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 45 |
| Q4 2022 | 51 |
| Q1 2023 | 48 |
| Q2 2023 | 45 |
| Q3 2023 | 45 |
| Q4 2023 | 42 |
| Q1 2024 | 39 |
| Q2 2024 | 36 |
| Q3 2024 | 32 |
| Q4 2024 | 28 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2023 | 4 | 8 |
| Q2 2023 | 7 | 9 |
| Q3 2023 | 1 | 10 |
| Q4 2023 | 5 | 9 |
| Q1 2024 | 9 | 17 |
| Q2 2024 | 7 | 9 |
| Q3 2024 | 4 | 5 |
| Q4 2024 | 0 | 8 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q1 2024 | $7.4k | $0 | 0.00 |
| Q2 2024 | $2.2k | $0 | 0.00 |
| Q3 2024 | $555 | $0 | 0.00 |
| Q4 2024 | $903 | $0 | 0.00 |
Biggest buyers
| None |
Biggest sellers
| COWEN AND COMPANY, LLC | Sold out | -737.2k |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | Reduced | -559.0k |
| Walleye Capital LLC | Sold out | -156.6k |
| Periscope Capital Inc. | Reduced | -151.5k |
| Walleye Trading LLC | Reduced | -17.7k |
| ROBINSON CAPITAL MANAGEMENT, LLC | Sold out | -355 |
| BANK OF AMERICA CORP /DE/ | Reduced | -300 |
| Pineridge Advisors LLC | Sold out | -150 |
Biggest calls
| MILLENNIUM MANAGEMENT LLC | Unchanged | $903108.8k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
No one currently above 5% in the filings since 19 Dec 2024.
Fell to 5% or below in the last year: Tibbs Isaiah (4.6%, 2026-08-14)
Insider purchases and sales in Q4 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2024-12-13 | YK Bioventures Opportunities GP I, LLC +3 10% owner · By YK Bioventures Opportunities Fund I, L.P. | Sold | $179.9k3.0m shares |
| 2024-12-12 | YK Bioventures Opportunities GP I, LLC +3 10% owner · By YK Bioventures Opportunities Fund I, L.P. | Sold | $113.0k1.6m shares |
| 2024-12-11 | YK Bioventures Opportunities GP I, LLC +3 10% owner · By YK Bioventures Opportunities Fund I, L.P. | Sold | —1.3m shares |
| 2024-12-10 | YK Bioventures Opportunities GP I, LLC +3 10% owner · By YK Bioventures Opportunities Fund I, L.P. | Sold | —1.6m shares |
| 2024-12-09 | YK Bioventures Opportunities GP I, LLC +3 10% owner · By YK Bioventures Opportunities Fund I, L.P. | Sold | —850.5k shares |
| 2024-12-06 | YK Bioventures Opportunities GP I, LLC +3 10% owner · By YK Bioventures Opportunities Fund I, L.P. | Sold | —1.2m shares |
| 2024-10-10 | YK Bioventures Opportunities GP I, LLC +3 10% owner · By YK Bioventures Opportunities Fund I, L.P. | Sold | —3.2m shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2024
| Manager | Shares | Change |
|---|---|---|
| CANTOR FITZGERALD, L. P. 0.00% of their portfolio | 441.0k $4.1k | Unchanged |
| MMCAP International Inc. SPC 0.00% of their portfolio | 375.0k $3.1k | Unchanged |
| Saba Capital Management, L.P. 0.00% of their portfolio | 295.9k $2.7k | Unchanged |
| Periscope Capital Inc. 0.00% of their portfolio | 274.0k $2.3k | Reduced -151.5k |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC 0.00% of their portfolio | 270.6k $2.2k | Reduced -559.0k |
| Clear Street Derivatives LLC 0.00% of their portfolio | 268.1k $2.2k | Unchanged |
| Linden Advisors LP 0.00% of their portfolio | 250.0k $2.3k | Unchanged |
| Blue Owl Capital Holdings LP 0.00% of their portfolio | 224.9k $2.2k | Unchanged |
| Q Global Advisors, LLC 0.00% of their portfolio | 170.8k $1.0k | Unchanged |
| CLEAR STREET LLC 0.00% of their portfolio | 145.2k $1.2k | Unchanged |
| Context Capital Management, LLC 0.00% of their portfolio | 122.0k $1.0k | Unchanged |
| NEXPOINT ASSET MANAGEMENT, L.P. 0.00% of their portfolio | 108.7k $903 | Unchanged |
| PICTON MAHONEY ASSET MANAGEMENT 0.00% of their portfolio | 75.0k $0 | Unchanged |
| Westchester Capital Management, LLC 0.00% of their portfolio | 75.0k $622 | Unchanged |
| Walleye Trading LLC 0.00% of their portfolio | 70.4k $584 | Reduced -17.7k |
| TENOR CAPITAL MANAGEMENT Co., L.P. 0.00% of their portfolio | 50.0k $415 | Unchanged |
| Yakira Capital Management, Inc. 0.00% of their portfolio | 50.0k $415 | Unchanged |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 43.8k $363 | Unchanged |
| WHITEBOX ADVISORS LLC 0.00% of their portfolio | 25.0k $208 | Unchanged |
| RIVERNORTH CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 25.0k $207 | Unchanged |
| Schonfeld Strategic Advisors LLC 0.00% of their portfolio | 15.0k $124 | Unchanged |
| DUPONT CAPITAL MANAGEMENT CORP 0.00% of their portfolio | 12.5k $104 | Unchanged |
| Calamos Advisors LLC 0.00% of their portfolio | 12.5k $104 | Unchanged |
| Silver Rock Financial LP 0.00% of their portfolio | 12.2k $101 | Unchanged |
| Ancora Advisors LLC 0.00% of their portfolio | 2.5k $21 | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 500 $4 | Reduced -300 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 87 $1 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |